These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 11243397)

  • 1. Medulloblastomas, CNS embryonal tumors, and cerebellar mutism syndrome: advances in care and future directions.
    Patel N; Keating G; Solanki GA; Syed HR; Keating RF
    Childs Nerv Syst; 2023 Oct; 39(10):2633-2647. PubMed ID: 37632526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies.
    Zahnreich S; Schmidberger H
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34073340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two cases of phenotypic switch of primary cutaneous T cell lymphoma after treatment with an aggressive course and review of the literature.
    Marks E; Shi Y; Wang Y
    Virchows Arch; 2019 Nov; 475(5):637-648. PubMed ID: 31218405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tongue cancer in young patients: case report of a 26-year-old patient.
    Credé A; Locher M; Bredell M
    Head Neck Oncol; 2012 May; 4():20. PubMed ID: 22583815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second malignant neoplasms and cardiovascular disease following radiotherapy.
    Travis LB; Ng AK; Allan JM; Pui CH; Kennedy AR; Xu XG; Purdy JA; Applegate K; Yahalom J; Constine LS; Gilbert ES; Boice JD
    J Natl Cancer Inst; 2012 Mar; 104(5):357-70. PubMed ID: 22312134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-risk populations identified in Childhood Cancer Survivor Study investigations: implications for risk-based surveillance.
    Hudson MM; Mulrooney DA; Bowers DC; Sklar CA; Green DM; Donaldson SS; Oeffinger KC; Neglia JP; Meadows AT; Robison LL
    J Clin Oncol; 2009 May; 27(14):2405-14. PubMed ID: 19289611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction.
    Xu XG; Bednarz B; Paganetti H
    Phys Med Biol; 2008 Jul; 53(13):R193-241. PubMed ID: 18540047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth retardation and bilateral cataracts followed by anaplastic meningioma 23 years after high-dose cranial and whole-body irradiation for acute lymphoblastic leukemia: case report and review of the literature.
    Korenkov AI; Imhof HG; Brandner S; Taub E; Huguenin PU; Gaab MR; Yonekawa Y
    J Neurooncol; 2005 Sep; 74(2):195-9. PubMed ID: 16193392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies.
    Kollmannsberger C; Hartmann JT; Kanz L; Bokemeyer C
    J Cancer Res Clin Oncol; 1998; 124(3-4):207-14. PubMed ID: 9619748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second malignancy after treatment of childhood acute myeloid leukemia.
    Leung W; Ribeiro RC; Hudson M; Tong X; Srivastava DK; Rubnitz JE; Sandlund JT; Razzouk BI; Evans WE; Pui CH
    Leukemia; 2001 Jan; 15(1):41-5. PubMed ID: 11243397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second malignancy after treatment of childhood non-Hodgkin lymphoma.
    Leung W; Sandlund JT; Hudson MM; Zhou Y; Hancock ML; Zhu Y; Ribeiro RC; Rubnitz JE; Kun LE; Razzouk B; Evans WE; Pui CH
    Cancer; 2001 Oct; 92(7):1959-66. PubMed ID: 11745271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study.
    Bhakta N; Liu Q; Yeo F; Baassiri M; Ehrhardt MJ; Srivastava DK; Metzger ML; Krasin MJ; Ness KK; Hudson MM; Yasui Y; Robison LL
    Lancet Oncol; 2016 Sep; 17(9):1325-34. PubMed ID: 27470081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia.
    Hijiya N; Hudson MM; Lensing S; Zacher M; Onciu M; Behm FG; Razzouk BI; Ribeiro RC; Rubnitz JE; Sandlund JT; Rivera GK; Evans WE; Relling MV; Pui CH
    JAMA; 2007 Mar; 297(11):1207-15. PubMed ID: 17374815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of acute lymphoblastic leukemia following treatment for acute myeloid leukemia in children with Down syndrome: A case report and retrospective review of Children's Oncology Group acute myeloid leukemia trials.
    Murphy BR; Roth M; Kolb EA; Alonzo T; Gerbing R; Wells RJ
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27700. PubMed ID: 30908863
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.